Results 21 to 30 of about 912,674 (310)

Psychiatry in Ukraine [PDF]

open access: yesInternational Psychiatry, 2006
Ukraine, at 603 700 km2, has the second largest landmass in Europe. It has a population of about 47.4 million. Ukraine is a lower-middle-income country with a gross national income per capita of US$1260 (World Bank, 2002).
Semyon, Gluzman, Stanislav, Kostyuchenko
openaire   +2 more sources

Mokryk, Radomyr: The birth of dissent: the 1960s and the thaw in Ukraine (1956 – 1965) [PDF]

open access: yesSlovenska Literatura
Mokryk, Radomyr: The birth of dissent: the 1960s and the thaw in Ukraine (1956 – 1965)
Olha Norba
doaj   +1 more source

Academician of NAMS of Ukraine, Rector of SE «DMA of Health Ministry of Ukraine» Georgy Viktorovych Dziak is 70 [PDF]

open access: yesMedičnì Perspektivi, 2015
Georgy Viktorovych ...
SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
doaj  

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study [PDF]

open access: yes, 2009
Background: Ukraine was the epicentre of the HIV epidemic in Eastern Europe, which has the most rapidly accelerating HIV epidemic world-wide today; national HIV prevalence is currently estimated at 1.6%.
Malyuta, R   +4 more
core  

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Prominent Movement Disorders in RNU2‐2‐Related Spliceosomopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Pediatric movement disorders often overlap with neurodevelopmental diseases, suggesting shared molecular mechanisms. Variants in small nuclear RNA (snRNA) genes encoding spliceosome components have recently been associated with neurodevelopmental disorders, termed “RNUopathies.” We analyzed genome sequencing data from 14 patients with ...
Magdalena Krygier   +6 more
wiley   +1 more source

Tackling the Informal Economy in Ukraine [PDF]

open access: yes, 2012
The problem of informal work and informal networks (blat) in Ukraine is long-standing. Until now, research on the informal economy in Ukraine has largely focused on measuring its size rather than exploring the nature and motives of the people engaged in ...
Onoshchenko, Olga
core  

Activities of the Assembly Center of the Ukrainian National Army in Vienna for Recruitment of Non-Ukrainian Soldiers to the Galician Army

open access: yesКиївські історичні студії, 2021
The article examines such a little-known phenomenon of national history as foreign military mercenaries, who helped Ukrainians defend their country’s independence.
Oleh Stetsyshyn
doaj   +1 more source

Solid‐State Diffusion and Intermetallic Phase Formation in Roll‐Bonded Mg–Zn Composites With Kirigami‐Patterned Inlay

open access: yesAdvanced Engineering Materials, EarlyView.
Mg–Zn composites with a thickness of 0.21 mm were fabricated using roll bonding of a kirigami‐patterned Mg alloy inlay within a Zn matrix. Thermal activation following this process led to the formation of tailored intermetallic structures, which provided the composite with enhanced flexural strength.
Yaroslav Frolov   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy